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Abstract: 
Background:Thromboembolic diseases are a major clinical problem due to their 
high prevalence and their often fatal consequences. In the present study, an 
anticoagulant galactoside binding C type lectin “Cc-Lec” was purified and 
characterized.  
Methods: Cc-Lec was purified by affinity chromatography on a column of 
Sepharose 4B coupled with D-lactose. Its homogeneity was verified by SDS-
PAGE and ESI-MS. Cc-Lec 3D structure modelization was achieved by 
homology to Convulxin a snake venom C type lectin. Cc-Lec anticoagulant effect 
was explored in vivo by i.p. administration to mice, invitro by native PAGE 
analysis and in silicoby protein-protein docking approach. 
Results: Cc-Lec is a 34 271,59 Da protein, composed of 160 residues of amino 
acids for each subunit. Its 3D structure is organized into a homodimer cross-
linked with a disulfide bridge and composed of three alpha helices and seven beta 
strands for each monomer. Cc-Lec functional characterization revealed a durable 
anticoagulant effect in vivo after 6 and 48h of i.p. administration to mice. This 
anticoagulant effect is mediated by interaction with FXa and FIXa as showed by 
native PAGE analysis. Moreover, protein-protein docking results reinforced this 
data and showed that Cc-Lec interacts with coagulation factors X and IX through 
their  -carboxyglutamic domains. The interaction with factors X and IX requires 
calcium or calcium and magnesium ions respectively. 
Conclusion: The anticoagulant effect of Cc-Lec makes it a promising 
pharmacological target for the diagnosis and/or the therapy of the thromboembolic 
diseases. 
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